Researchers discover a noninvasive, low-cost test to detect oral cancer

FHS
March 4, 2024
5:52 pm

Oral cancers and precancerous mouth lesions are considered especially difficult to diagnose early and accurately.

New Treatment Approved for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA expanded the indication of efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) Friday to include treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP), drugmaker

June 24, 2024

U.S. Attempts to Get Its Xylazine Problem Under Control

In February, we reported on the emerging problem of xylazine-laced fentanyl. In this report, we follow up on what has happened since doctors first started

December 31, 2023

Scientists map cancer mutations in EGFR gene, revealing drug resistance paths

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance, paving the way for personalized treatment

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.